In a Neutral regime, JNJ's AIQ Score of 62/100 with Quality base of 85/100 and fading Momentum at 64/100 (Δ-23) signals mixed conviction. Wait for component alignment before adding exposure. Watch momentum trend for confirmation or fading.
Valuation (47/100) is diverging from Momentum (64/100) and Sentiment (68/100) and Quality (85/100). JNJ's strong momentum and positive signals are running ahead of fundamental value — a setup that has historically required monitoring for mean reversion. Watch for RSI overbought signals as a confirmation trigger.
Quick Stats
JNJ's 7-day signal profile is softening with AIQ change of -7.0 points and momentum delta of -23.0. Trend delta is -7.00, which helps frame whether the current move is accelerating or fading.
Snapshot: Wed, 15 Jul 2026 00:00:00 GMT. Baseline: 2026-07-07.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AI Analysis Report
Scenario Analysis
AIQ Scenario Builder
JNJ (JNJ) Stock Analysis
JNJ (JNJ) has an AIQ Score of 62/100 in a Neutral regime as of Jul 15, 2026. Quality is strongest at 85/100. Risk is weakest at 46/100. The main conflict is that quality remains supportive at 85/100 while 7-day momentum is fading (-23.0 pts).
JNJ (JNJ) carries an AIQ Score of 62 out of 100, placing it in a mixed signal regime for this snapshot. A mid-range reading typically means component signals are not fully aligned, so interpretation should focus on what is improving versus what is lagging.
Beta is 0.33, implying roughly 67% lower sensitivity than a broad market baseline.
In the latest weekly profile, AIQ has moved -7.0 points over the last 7 days, momentum delta is -23.0, trend delta is -7.00, risk delta is -3.0. This combination is most useful for judging whether signal quality is strengthening or fading into mean reversion.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | JNJ is in a Neutral AIQ regime with score 62/100. |
| Signal Conflict | The primary conflict is that quality remains supportive at 85/100 while 7-day momentum is fading (-23.0 pts). |
| Factor Evidence | Momentum 64/100 · Value 47/100 · Quality 85/100 · Risk 46/100 · Sentiment 68/100 |
| Persistence | Score-history persistence is not available for this symbol yet. |
| Checklist | Status | Evidence |
|---|---|---|
| Factor strength | Pass | Quality is the strongest factor at 85/100. |
| Timing | Pass | Momentum is 64/100 with 7-day delta -23.0. |
| Regime fit | Pass | JNJ is in a Neutral regime at 62/100. |
| Risk control | Wait | Risk factor is 46/100 with beta of 0.33 implies lower sensitivity than the broader market. |
| Conflict | Wait | Current conflict: quality remains supportive at 85/100 while 7-day momentum is fading (-23.0 pts). |
JNJ's 7-day signal profile is softening with AIQ change of -7.0 points and momentum delta of -23.0. Trend delta is -7.00, which helps frame whether the current move is accelerating or fading.
Signal snapshot as of Wed, 15 Jul 2026 00:00:00 GMT. 7-day comparison baseline: 2026-07-07.
| Metric | Current |
|---|---|
| AIQ Score | 62/100 |
| Price | $247.02 |
| Beta | 0.33 |
JNJ vs Healthcare Peers
Portfolio Implication
Related Links
JNJ Stock FAQ
What does the JNJ AIQ Score mean?
AIQ Score summarizes multiple factors for JNJ, including momentum, value, quality, and risk. Higher scores generally indicate stronger combined signals, but you should still validate with your own risk tolerance.
How often is JNJ data updated?
JNJ quote and scoring components refresh on the platform cadence. Always confirm timestamp freshness on-page before making time-sensitive decisions.
Should I compare JNJ with an index before investing?
Yes. Comparing JNJ versus benchmarks like SPY or QQQ helps you separate stock-specific strength from broader market moves.
Where can I review deeper JNJ fundamentals, technicals, and risk?
Use the Fundamentals, Technicals, and Risk tabs from this page to inspect driver-level metrics behind the headline score.
How the AIQ Score Is Built
Methodology, factor weights, and how to interpret score history
Loading JNJ...